Therefore, to test the involvement of RhoA in CGN migration, we used the Rho kinase inhibitor, Y27632, to block the RhoA signaling pathway and analyzed CGN migration using the transwell assay. The gene discussed is RHOA; the disease is childhood gender nonconformity.